ROTGERI ANDREA
No ORCID on file
· 15 papers in corpus
other
2012
The invention relates to 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives of formula (I) exhibiting progesterone-antagonistic effects and to methods for the production thereof, to the use thereof for the treatment and/or…
other
2012
The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of Formula I with progesterone antagonizing action and method of production thereof, use thereof for the treatment and/or prophylaxis of diseases…
2011
The invention relates to 17-hydroxy-13-methyl-17-pentafluorethyl-11-acyloxyalkylenephenyl-dodecahydro-cyclopenta[a]phenanthrene-3-on derivatives of formula (I) exhibiting progesterone-antagonistic effects and to methods for the production t…
2011
The invention relates to 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives of formula (I) exhibiting progesterone-antagonistic effects and to methods for the production thereof, to the use thereof for the treatment and/or…
2011
The invention relates to 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives of formula (I) exhibiting progesterone-antagonistic effects and to methods for the production thereof, to the use thereof for the treatment and/or…
2011
The invention relates to a 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11methylene oxyalkylene aryl derivative of formula (I) exhibiting progesterone-antagonistic effects and to methods for the production thereof, to the use thereof fo…
other
2009
Amide compounds (I), are new. Amide compounds of formula (I), are new. q : 0 or 1 R 1>mono or bicyclic 6-12C aryl, 5-12 membered hetero aryl, 3-10C cycloalkyl, or 3-10 membered hetero cycloalkyl residue, which is unsubstituted or substitute…
2009
The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise the…
2009
The present invention relates to non-steroidal progesterone receptor modulators of the general formula I the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compositions which comprise these compoun…
2009
The present invention relates to non-steroidal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise the…
2009
The present invention relates to nonsteriodal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for producing medicaments and also pharmaceutical compositions containing these compoun…
other
2008
Amide compounds (I), are new. Amide compounds of formula (I), are new. A : H, Z substituted 1-8C-alkyl, 2-8C-alkenyl, 2-8C alkinyl, M substituted 3-10C-cycloalkyl, 3-12-membered heterocycloalkyl residue, where Z is cyano, halogen, hydroxy, …
other
2008
The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise the…
other
2008
The invention relates to non-steroidal progesterone receptor modulators of general formula (I), use of the progesterone receptor modulators for the production of medicaments and pharmaceutical compositions containing said compounds. Said co…
other
2008
The invention relates to non-steroidal progesterone receptor modulators of general formula (I), use of the progesterone receptor modulators for the production of medicaments and pharmaceutical compositions containing said compounds. Said co…